James Markowitz

14.9k total citations · 3 hit papers
121 papers, 7.3k citations indexed

About

James Markowitz is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, James Markowitz has authored 121 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Genetics, 64 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in James Markowitz's work include Inflammatory Bowel Disease (90 papers), Microscopic Colitis (60 papers) and Adolescent and Pediatric Healthcare (17 papers). James Markowitz is often cited by papers focused on Inflammatory Bowel Disease (90 papers), Microscopic Colitis (60 papers) and Adolescent and Pediatric Healthcare (17 papers). James Markowitz collaborates with scholars based in United States, Canada and Israel. James Markowitz's co-authors include Jeffrey S. Hyams, Anne M. Griffiths, Fredric Daum, Subra Kugathasan, Dan Turner, Wallace Crandall, Thomas D. Walters, Arie Levine, Anthony Otley and Nina Kohn and has published in prestigious journals such as Nature Communications, Physiological Reviews and SHILAP Revista de lepidopterología.

In The Last Decade

James Markowitz

117 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pediatric modification of the Montreal classification for inflammatory bowel disease

2010 1.1k citations Arie Levine, Anne M. Griffiths et al. Inflammatory Bowel Diseases profile →
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

2006 662 citations Jeffrey S. Hyams, Wallace Crandall et al. Gastroenterology profile →
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

2000 510 citations James Markowitz, Nina Kohn et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Markowitz United States	41	5.7k	4.2k	2.3k	1.4k	948	121	7.3k
Subra Kugathasan United States	47	5.1k 0.9×	3.4k 0.8×	2.2k 0.9×	1.7k 1.2×	807 0.9×	175	7.8k
Thomas D. Walters Canada	35	3.7k 0.6×	2.8k 0.7×	1.8k 0.8×	1.0k 0.7×	409 0.4×	116	5.4k
George D. Ferry United States	33	3.3k 0.6×	2.2k 0.5×	1.7k 0.7×	806 0.6×	476 0.5×	100	5.4k
Gary R. Lichtenstein United States	44	5.7k 1.0×	4.6k 1.1×	2.3k 1.0×	1.4k 1.0×	464 0.5×	237	8.6k
Russell D. Cohen United States	47	6.7k 1.2×	5.2k 1.3×	2.7k 1.2×	1.6k 1.2×	494 0.5×	210	9.0k
Alain Bitton Canada	45	4.6k 0.8×	3.4k 0.8×	2.3k 1.0×	1.4k 1.0×	269 0.3×	203	7.1k
Ian Arnott United Kingdom	36	4.0k 0.7×	3.1k 0.7×	1.9k 0.8×	1.0k 0.7×	233 0.2×	132	5.4k
Joel R. Rosh United States	32	2.4k 0.4×	1.7k 0.4×	1.0k 0.4×	648 0.5×	523 0.6×	137	3.9k
Gerassimos J. Mantzaris Greece	41	8.0k 1.4×	6.3k 1.5×	3.4k 1.5×	1.9k 1.3×	480 0.5×	145	10.5k
Brian Bressler Canada	38	4.5k 0.8×	3.8k 0.9×	2.2k 0.9×	1.9k 1.3×	402 0.4×	237	7.8k

Countries citing papers authored by James Markowitz

Since Specialization

Citations

This map shows the geographic impact of James Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Markowitz more than expected).

Fields of papers citing papers by James Markowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Markowitz. The network helps show where James Markowitz may publish in the future.

Co-authorship network of co-authors of James Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of James Markowitz. A scholar is included among the top collaborators of James Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Markowitz. James Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Geem, Duke, David M. Hercules, Suresh Venkateswaran, et al.. (2023). Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clinical Gastroenterology and Hepatology. 22(2). 368–376.e4. 9 indexed citations

2.

Sahn, Benjamin, et al.. (2023). Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial. SHILAP Revista de lepidopterología. 9(1). 23–23. 23 indexed citations

3.

Levine, Arie, Anne M. Griffiths, James Markowitz, et al.. (2010). Pediatric modification of the Montreal classification for inflammatory bowel disease. Inflammatory Bowel Diseases. 17(6). 1314–1321. 1054 indexed citations breakdown →

4.

Hyams, Jeffrey S., Trudy Lerer, Anne M. Griffiths, et al.. (2010). Outcome Following Infliximab Therapy in Children With Ulcerative Colitis. The American Journal of Gastroenterology. 105(6). 1430–1436. 87 indexed citations

5.

Punati, Jaya, James Markowitz, Trudy Lerer, et al.. (2008). Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflammatory Bowel Diseases. 14(7). 949–954. 83 indexed citations

6.

Kappelman, Michael D., Athos Bousvaros, Jeffrey S. Hyams, et al.. (2007). Intercenter variation in initial management of children with Crohnʼs disease. Inflammatory Bowel Diseases. 13(7). 890–895. 58 indexed citations

7.

Mack, David R., Christine R. Langton, James Markowitz, et al.. (2007). Laboratory Values for Children With Newly Diagnosed Inflammatory Bowel Disease. PEDIATRICS. 119(6). 1113–1119. 110 indexed citations

8.

Markowitz, James, et al.. (2006). Update in the treatment of paediatric ulcerative colitis. Expert Opinion on Pharmacotherapy. 7(14). 1907–1918. 3 indexed citations

9.

Hyams, Jeffrey S., Wallace Crandall, Subra Kugathasan, et al.. (2006). Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children. Gastroenterology. 132(3). 863–873. 662 indexed citations breakdown →

10.

Markowitz, James, Jeffrey S. Hyams, David Mack, et al.. (2006). Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 4(9). 1124–1129. 76 indexed citations

11.

Hyams, Jeffrey S. & James Markowitz. (2005). Can We Alter The Natural History Of Crohn Disease In Children?. Journal of Pediatric Gastroenterology and Nutrition. 40(3). 262–272. 32 indexed citations

12.

Daum, Fredric, James Markowitz, Jeremiah Levine, et al.. (2004). Effects of Infliximab on Apoptosis and Reverse Signaling of Monocytes from Healthy Individuals and Patients with Crohn’s Disease. Inflammatory Bowel Diseases. 10(6). 801–810. 60 indexed citations

13.

Levine, Arie, et al.. (2003). Consensus and Controversy in the Management of Pediatric Crohn Disease: An International Survey. Journal of Pediatric Gastroenterology and Nutrition. 36(4). 464–469. 13 indexed citations

14.

Baldassano, Robert N., George D. Ferry, Anne Griffiths, et al.. (2002). Transition of the Patient With Inflammatory Bowel Disease From Pediatric to Adult Care: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 34(3). 245–248. 132 indexed citations

15.

Büller, Hans A., Simon Chin, Barbara S. Kirschner, et al.. (2002). Inflammatory Bowel Disease in Children and Adolescents: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 35(S2). 3 indexed citations

16.

Büller, Hans A., Simon Chin, Barbara S. Kirschner, et al.. (2002). Inflammatory Bowel Disease in Children and Adolescents: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 35. S151–S158. 18 indexed citations

17.

Beneck, Debra, et al.. (2002). Atypical Morphologic Presentation of Biliary Atresia and Value of Serial Liver Biopsies. Journal of Pediatric Gastroenterology and Nutrition. 34(2). 212–215. 58 indexed citations

18.

Markowitz, James, et al.. (2000). A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 119(4). 895–902. 510 indexed citations breakdown →

19.

Hyams, Jeffrey S., et al.. (1996). Clinical outcome of ulcerative colitis in children. The Journal of Pediatrics. 129(1). 81–88. 122 indexed citations

20.

Kahn, Ellen, James Markowitz, Edwin Simpser, Harvey Aiges, & Fredric Daum. (1989). Amyloidosis in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 8(4). 447–453. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact